Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

HilleVax Has Completed The Enrollment In NEST-IN1 Phase 2B Trial For Hil-214 Vaccine, With Over 3,000, To Prevent Moderate-to-severe Norovirus-related Acute Gastroenteritis In Infants. Topline Safety And Clinical Efficacy Data Are Expected In Q1 Of 2024

Author: Benzinga Newsdesk | April 25, 2023 06:56am

Posted In: HLVX